Effect of angiotensin converting enzyme inhibitors on oxidative stress, endothelial function in patients with myocardial infarction

Kardiologiya

Volumn 49, Issue 7-8, 2009, Pages 32-37

  Zadionchenko, V S ^a   Leksina, K S ^a   Timofeeva, N Y U ^a   Shekhyan, C G ^a   Bagatyrova, K M ^a   Mironova, M A ^a  

^a A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

Author keywords

Angiotensin converting enzyme inhibitors; Endothelial function; Lipid peroxidation; Myocardial infarction; Oxidative stress; Stress proteins.

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SPECTROPHOTOMETRY; TIME; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350059355     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Peterson E.D., Shaw L.J., Catiff R.M. Risk stratification after myocardial infarction. Ann Intern Med 1997;126:561-682.
2. Hill M.F., Singgl P-K. Antioxidant and oxidative stress changes Failure Subsequent to Myocardial Infarction in Rats. Am J Pathol 1996;148:291-300. (Pubitemid 26019664)
3. Esterbauer H., Wang G., Puhl H. Lipid peroxidation and its role in atherosderosis. Br Med Bull 1993;49:566-576. (Pubitemid 23243830)
4. Ford J., Robertson M., Gase D. et al. Prognostic value of hsCRP in patients with stable coronary disease and angina of effort, univariates and in the presense of N-terminal BNP and other risk factors. JACC 2005;45(Suppl. A):212A.
5. Shindo T., Ikeda U., Ohkawa F. et al. Nitric oxide synthesis in cardiac myocytes and fibroblast by inflammatory cytokines. Cardiovasc Res 1995;29:813-818.
6. The World Health Report 2001. Geneva: WHO 2001.
7. Borghi C. et al Double-blind comparison between Zofenopril and lisinopril in patients with acute myocardial infarction: Results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. Am Heart J 2003; 145:80087.
8. Borghi C. et al. Effects of Zofenopril on ischaemia following myocardial infarction: The SMILE study. AHA scientific sessions. 2003.
9. Chinese Cardiac Study Collaborative Group. Oral Captopril versus placebo among 13634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-I). Lancet 1995;345:686-687.
10. Scriber A.W., Loscalzo J., Napoli C. The effect of angiotensin converting enzyme inhibition on endothelial function and oxidant stress. Eur J Pharmacol 2003;482:95-99. (Pubitemid 37505931)